RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 119 filers reported holding RUBIUS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $184,000 | -49.2% | 425,497 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $362,000 | -85.4% | 425,497 | -5.8% | 0.00% | -80.0% |
| Q1 2022 | $2,487,000 | +2140.5% | 451,505 | +3765.3% | 0.01% | +400.0% |
| Q4 2019 | $111,000 | -96.1% | 11,681 | -92.7% | 0.00% | -92.9% |
| Q1 2019 | $2,878,000 | – | 159,046 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |